1. Home
  2. BNTC vs OOMA Comparison

BNTC vs OOMA Comparison

Compare BNTC & OOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • OOMA
  • Stock Information
  • Founded
  • BNTC 1995
  • OOMA 2003
  • Country
  • BNTC United States
  • OOMA United States
  • Employees
  • BNTC N/A
  • OOMA N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • OOMA EDP Services
  • Sector
  • BNTC Health Care
  • OOMA Technology
  • Exchange
  • BNTC Nasdaq
  • OOMA Nasdaq
  • Market Cap
  • BNTC 335.5M
  • OOMA 379.7M
  • IPO Year
  • BNTC N/A
  • OOMA 2015
  • Fundamental
  • Price
  • BNTC $12.99
  • OOMA $12.05
  • Analyst Decision
  • BNTC Strong Buy
  • OOMA Buy
  • Analyst Count
  • BNTC 5
  • OOMA 6
  • Target Price
  • BNTC $26.00
  • OOMA $17.63
  • AVG Volume (30 Days)
  • BNTC 41.1K
  • OOMA 112.4K
  • Earning Date
  • BNTC 09-25-2025
  • OOMA 08-26-2025
  • Dividend Yield
  • BNTC N/A
  • OOMA N/A
  • EPS Growth
  • BNTC N/A
  • OOMA N/A
  • EPS
  • BNTC N/A
  • OOMA N/A
  • Revenue
  • BNTC N/A
  • OOMA $259,382,000.00
  • Revenue This Year
  • BNTC N/A
  • OOMA $6.33
  • Revenue Next Year
  • BNTC N/A
  • OOMA $6.15
  • P/E Ratio
  • BNTC N/A
  • OOMA N/A
  • Revenue Growth
  • BNTC N/A
  • OOMA 7.01
  • 52 Week Low
  • BNTC $8.06
  • OOMA $8.25
  • 52 Week High
  • BNTC $17.15
  • OOMA $17.00
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 58.50
  • OOMA 56.72
  • Support Level
  • BNTC $12.04
  • OOMA $11.32
  • Resistance Level
  • BNTC $13.09
  • OOMA $11.80
  • Average True Range (ATR)
  • BNTC 0.63
  • OOMA 0.28
  • MACD
  • BNTC 0.18
  • OOMA 0.11
  • Stochastic Oscillator
  • BNTC 93.47
  • OOMA 94.44

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About OOMA Ooma Inc.

Ooma Inc is a communications services company. It is a smart software-as-a-service ("SaaS") and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. Ooma generates revenues from the sale of subscriptions and other services.

Share on Social Networks: